独特的探索引擎发掘抗体许可机会
抗体持续拓宽可成药靶点和可治疗疾病的界限。Yet bringing a biologic to market, even one that promises to be first- or best-in-class, is filled with preclinical and clinical obstacles that can’t be overcome alone.
At Twist Biopharma Solutions, we're seeking partnerships with academic, biotech, and biopharma teams to help us translate lead assets from our unique discovery and optimization platform into clinical successes. 通过密切合作,我们可以在战略治疗领域挣脱难成药靶标的桎梏,确保没有疾病被贴上“无法治愈”的标签,全面惠及所有患者。
我们的治疗重点
With our discovery, optimization, and characterization capabilities as our foundation, we’ve made expanding your pipeline in important indications simple.
Our Asset Pipeline
Our pipeline is dedicated to tackling challenging targets and discovering high-potential assets with promising pharmacology. With our end-to-end antibody development capabilities, we’ve assembled promising preclinical data packages to springboard you into the clinic.
Schedule a meeting to learn more about our flexible partnering options and data packages for asset licensing.
为什么与 Twist 合作?
有兴趣深入了解我们独特的抗体许可机会吗?
Partner with Twist Biopharma Solutions to shape the future of antibody therapeutics. Our de-risked preclinical assets bring promise and potential to your pipeline. They are the product of our best-in-class discovery, optimization, and characterization platforms. See how we can help unlock new opportunities and strategic positioning in biopharma.
联系我们
我们的抗体专家随时待命,并希望听到更多关于您的发现需求的信息。欢迎挑战性目标!